LNWTC
TAK icon

Laird Norton Wetherby Trust Company’s Takeda Pharmaceutical TAK Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$888K Buy
54,386
+2,197
+4% +$36.4K 0.02% 546
2026
Q1 		$967K Buy
52,189
+1,977
+4% +$34.7K 0.02% 498
2025
Q4 		$783K Buy
+50,212
New +$718K 0.02% 565

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Laird Norton Wetherby Trust Company's TAK Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Takeda Pharmaceutical (TAK) stake by 4.2% in Q2 2026, buying an estimated $36.4K and bringing the position to 54,386 shares worth $888K. The position accounts for 0.02% of the portfolio, ranked #546.

Laird Norton Wetherby Trust Company first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. The position peaked at $967K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 54,386 shares of Takeda Pharmaceutical worth $888K as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 2,197 Takeda Pharmaceutical shares in Q2 2026, an estimated $36.4K.
  • Takeda Pharmaceutical made up 0.02% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #546 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Takeda Pharmaceutical position peaked at $967K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.